Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being

por Brod, Meryl, Pohlman, Betsy, Wolden, Michael, Christensen, Torsten
Publicado 2012

Cost of Self-Monitoring of Blood Glucose in the United States Among Patients on an Insulin Regimen for Diabetes

por Yeaw, Jason, Lee, Won Chan, Aagren, Mark, Christensen, Torsten
Publicado 2012

Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom

por Levy, Adrian R, Christensen, Torsten LU, Johnson, Jeffrey A
Publicado 2008

Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials

por Vora, Jiten, Christensen, Torsten, Rana, Azhar, Bain, Steve C.
Publicado 2014

Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device)

por Brod, Meryl, Hammer, Mette, Christensen, Torsten, Lessard, Suzanne, Bushnell, Donald M
Publicado 2009

Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures

por Brod, Meryl, Christensen, Torsten, Hammer, Mette, Busk, Anne K., Bushnell, Donald M.
Publicado 2011

Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes

por Yeaw, Jason, Lee, Won Chan, Wolden, Michael Lyng, Christensen, Torsten, Groleau, Danielle
Publicado 2012

Patient treatment satisfaction after switching to NovoMix(®) 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors

por Brod, Meryl, Valensi, Paul, Shaban, Joseph A., Bushnell, Don M., Christensen, Torsten L.
Publicado 2010